News about "never-smokers "

Lantern Pharma Gets Regulatory Approval to Expand Harmonic Clinical Trial for NSCLC

Lantern Pharma Gets Regulatory Approval to Expand Harmonic Clinical Trial for NSCLC

Lantern Pharma Inc. has secured regulatory approval to expand its Harmonic trial, a Phase 2 clinical study evaluating LP-300 in non-small cell lung cancer (NSCLC) in never-smokers in both Japan and Taiwan.

Never-smokers | 23/04/2024 | By Aishwarya


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members